Netherton syndrome, enteropathic acrodermatitis, and zinc

Efficacy of anti-PD1 therapy in PD1-high mRNA tumors across multiple cancer types: results from cohort 1 and cohort 2 of the phase II SOLTI-1904 ACROPOLI trial.

ESMO open·2025

Magnetic resonance imaging findings for inflammatory mastitis of unknown etiology.

Radiologia·2024

The xenobiotic transporter ABCC4/MRP4 promotes epithelial mesenchymal transition in pancreatic cancer.

Frontiers in pharmacology·2024

[Acute symptomatic epileptic seizures. A clinical-electroencephalographic etiological description and prognosis of an oncopediatric series].

Revista de neurologia·2024

Multiantigen print immunoassay (MAPIA) for the diagnosis of neurocysticercosis: a single-center diagnostic optimization and accuracy study in Lima, Peru.

Journal of clinical microbiology·2023

The Arabidopsis holobiont: a (re)source of insights to understand the amazing world of plant-microbe interactions.

Environmental microbiome·2023

Belzutifan plus lenvatinib versus cabozantinib in patients with previously treated advanced renal cell carcinoma (LITESPARK-011): an open-label, randomised, controlled, phase 3 trial.

Lancet (London, England)·2026

Switch to once-weekly, single-tablet islatravir-lenacapavir from daily standard of care for HIV-1 (ISLEND-2): a multicentre, randomised, open-label, active-controlled, phase 3 non-inferiority trial.

Lancet (London, England)·2026

[177Lu]Lu-PSMA-617 in patients with PSMA-positive metastatic androgen pathway modulator-naive/sensitive prostate cancer (PSMAddition): a phase 3 randomised, controlled trial.

Lancet (London, England)·2026

The Role of IGF-1 and IL-10 in Childhood Stunting: Evidence From Indonesia.

TheScientificWorldJournal·2026

Role of glucagon in metabolic diseases.

Journal of diabetes investigation·2026

Are sustainable plant-based diets suitable for all? A nutrigenetic perspective.

Nutrition and health·2026

Systematic Screening of Tryptophan Metabolism Identifies Site- and Microbiota-Dependent Signatures of Tryptophan Utilization in Experimental Colitis.

International journal of tryptophan research : IJTR·2026

Therapeutic potential and research progress of microecological agents in kidney diseases.

Frontiers in medicine·2026

Gut microbiota-immune crosstalk in childhood and adolescent obesity: mechanistic insights and therapeutic potential focused on short-chain fatty acids and emerging metabolites.

Frontiers in microbiology·2026

Related Experiment Videos

Netherton syndrome, enteropathic acrodermatitis, and zinc

Related Concept Videos

Efficacy of anti-PD1 therapy in PD1-high mRNA tumors across multiple cancer types: results from cohort 1 and cohort 2 of the phase II SOLTI-1904 ACROPOLI trial.

Magnetic resonance imaging findings for inflammatory mastitis of unknown etiology.

The xenobiotic transporter ABCC4/MRP4 promotes epithelial mesenchymal transition in pancreatic cancer.

[Acute symptomatic epileptic seizures. A clinical-electroencephalographic etiological description and prognosis of an oncopediatric series].

Multiantigen print immunoassay (MAPIA) for the diagnosis of neurocysticercosis: a single-center diagnostic optimization and accuracy study in Lima, Peru.

The Arabidopsis holobiont: a (re)source of insights to understand the amazing world of plant-microbe interactions.

Belzutifan plus lenvatinib versus cabozantinib in patients with previously treated advanced renal cell carcinoma (LITESPARK-011): an open-label, randomised, controlled, phase 3 trial.

Switch to once-weekly, single-tablet islatravir-lenacapavir from daily standard of care for HIV-1 (ISLEND-2): a multicentre, randomised, open-label, active-controlled, phase 3 non-inferiority trial.

[177Lu]Lu-PSMA-617 in patients with PSMA-positive metastatic androgen pathway modulator-naive/sensitive prostate cancer (PSMAddition): a phase 3 randomised, controlled trial.

The Role of IGF-1 and IL-10 in Childhood Stunting: Evidence From Indonesia.

Role of glucagon in metabolic diseases.

Are sustainable plant-based diets suitable for all? A nutrigenetic perspective.

Systematic Screening of Tryptophan Metabolism Identifies Site- and Microbiota-Dependent Signatures of Tryptophan Utilization in Experimental Colitis.

Therapeutic potential and research progress of microecological agents in kidney diseases.

Gut microbiota-immune crosstalk in childhood and adolescent obesity: mechanistic insights and therapeutic potential focused on short-chain fatty acids and emerging metabolites.

Related Experiment Videos

Netherton syndrome, enteropathic acrodermatitis, and zinc

Related Concept Videos

Related Articles